home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Dean Dalton

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
Data Management & IT Solutions
Cloud-Based Compliance Software

Secure Environment

Constantly validated, secure data can be achieved through cloud-based compliance systems. However, several myths surround their implementation – James Brown of Zinc Ahead explains why these can be cast aside.
Therapeutic Innovation
Ageing Populations

Beyond a Single Pill

Capsugel’s Sven Stegemann describes why a ‘one-size-fits-all’ approach to drug design is no longer sufficient in the treatment of diseases of ageing. Various patient-centric products should be explored – and are sometimes essential to adherence in elderly populations.
  Clinical Trials: Patient Recruitment & Retention
Social Media

Get Connected

The Medical Research Network's Graham Wylie assures us that the major concerns in using social media in clinical trials are all relatively easy to address, as well as discussing the advantages of utilising such tools – many of which are only just being realised by pharma.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of Woodley.EPC on Samedan
Industry Events

Partnerships in Clinical Trials

5-6 November 2014, CCIB, Barcelona, Spain

Creators, innovators, storytellers and rising stars will come together at the 13th Annual Partnerships in Clinical Trials Congress, 5-6 November 2014 at the CCIB, Barcelona, Spain to provoke change and demand solutions to advancing clinical trial collaborations.
More info >>

News and Press Releases

Catalent Expands Its Technology Offerings in Biologics, Acquires Redwood Bioscience Inc. and the SMARTag(TM) Technology Platform

SOMERSET, N.J., Oct 02, 2014  -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology platform. In Catalent’s first acquisition since its IPO in July, the company continues to execute its strategy to build a differentiated technology offering and strengthen its position in the fast growing biologics market.
More info >>

air transport logo


White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement